Compare MasterCard Inc (MA) vs Select Medical Holdings Corporation (SEM) Price & Performance

Mastercard (MA) trades at $545.00, up 0.26% today, with strong technical support at $540 and resistance at $547. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding expectations of $4.41. Revenue grew to $32.79B in 2025, and net income margin remains high at 45.88%. Analysts maintain a bullish consensus with a $634.27 price target, citing momentum in digital payments and AI integration.

Outlook remains positive given consistent earnings outperformance and strategic initiatives in AI and financial inclusion. Key risks include competitive disruption from stablecoins and elevated valuation multiples. Institutional ownership trends show continued accumulation, supporting the bullish sentiment. The stock presents a growth opportunity but requires monitoring of payment industry evolution and valuation sustainability.

Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, following its recent acquisition completion by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported 2025 revenue of $5.45 billion with a net income margin of 2.42%, while valuation ratios like a P/E of 15.43 and P/S of 0.36 appear reasonable. Recent earnings show two misses in the last three quarters against expectations.

The investment outlook is dominated by the completed acquisition, effectively capping upside near the $16.50 deal price. Risks include ongoing shareholder litigation alleging fiduciary breaches by the board regarding the buyout fairness. Analyst sentiment is neutral with a Hold-heavy consensus, while the stock's future price action will largely hinge on legal outcomes surrounding the acquisition terms rather than operational performance.